Hong G - Search Results

1

Elexacaftor/Tezacaftor/Ivacaftor Markedly Reduces Aspergillus fumigatus in Cystic Fibrosis.

Morgan SJ, Nichols DP, Ni W, Hong G, Salipante SJ, Solomon GM, Rowe SM, Clancy JP, Cramer RA, Singh PK. Morgan SJ, et al. Among authors: hong g. Am J Respir Crit Care Med. 2024 Nov 1;210(9):1155-1158. doi: 10.1164/rccm.202406-1128RL. Am J Respir Crit Care Med. 2024. PMID: 39189854 No abstract available.

2

The Clinical Association between Aspergillus fumigatus and Respiratory Outcomes in Adolescents and Adults with Cystic Fibrosis.

O'Dea AL, Feng R, Glaser LJ, Kubrak C, Rubenstein RC, Dorgan DJ, Hadjiliadis D, Kawut SM, Hong G. O'Dea AL, et al. Among authors: hong g. Ann Am Thorac Soc. 2023 Jul;20(7):984-992. doi: 10.1513/AnnalsATS.202210-852OC. Ann Am Thorac Soc. 2023. PMID: 36800434

3

The Real-World Effectiveness of Antifungals in People with Cystic Fibrosis and Aspergillus-Positive Cultures.

Faerber JA, Kawut SM, Hadjiliadis D, Hong G. Faerber JA, et al. Among authors: hong g. Ann Am Thorac Soc. 2024 Oct 10. doi: 10.1513/AnnalsATS.202312-1070OC. Online ahead of print. Ann Am Thorac Soc. 2024. PMID: 39388639

4

An Observational Study of Outcomes and Tolerances in Patients with Cystic Fibrosis Initiated on Lumacaftor/Ivacaftor.

Jennings MT, Dezube R, Paranjape S, West NE, Hong G, Braun A, Grant J, Merlo CA, Lechtzin N. Jennings MT, et al. Among authors: hong g. Ann Am Thorac Soc. 2017 Nov;14(11):1662-1666. doi: 10.1513/AnnalsATS.201701-058OC. Ann Am Thorac Soc. 2017. PMID: 28406713

5

Risk factors for persistent Aspergillus respiratory isolation in cystic fibrosis.

Hong G, Psoter KJ, Jennings MT, Merlo CA, Boyle MP, Hadjiliadis D, Kawut SM, Lechtzin N. Hong G, et al. J Cyst Fibros. 2018 Sep;17(5):624-630. doi: 10.1016/j.jcf.2018.01.008. Epub 2018 Feb 12. J Cyst Fibros. 2018. PMID: 29444760 Free PMC article.

6

Endobronchial valve placement in secondary pneumothorax related to allergic bronchopulmonary aspergillosis.

Ramadurai D, DiBardino DM, Hong G. Ramadurai D, et al. Among authors: hong g. Respir Med Case Rep. 2021 Nov 10;34:101554. doi: 10.1016/j.rmcr.2021.101554. eCollection 2021. Respir Med Case Rep. 2021. PMID: 34820259 Free PMC article.

7

Progress and challenges in fungal lung disease in cystic fibrosis.

Hong G. Hong G. Curr Opin Pulm Med. 2022 Nov 1;28(6):584-590. doi: 10.1097/MCP.0000000000000921. Epub 2022 Sep 19. Curr Opin Pulm Med. 2022. PMID: 36101907 Free PMC article. Review.

8

Biliary disease and cholecystectomy after initiation of elexacaftor/ivacaftor/tezacaftor in adults with cystic fibrosis.

Safirstein J, Grant JJ, Clausen E, Savant D, Dezube R, Hong G. Safirstein J, et al. Among authors: hong g. J Cyst Fibros. 2021 May;20(3):506-510. doi: 10.1016/j.jcf.2020.07.014. Epub 2020 Jul 29. J Cyst Fibros. 2021. PMID: 32736949 Free article.

9

Inhaled antibiotic use is associated with Scedosporium/Lomentospora species isolation in cystic fibrosis.

Hong G, Lechtzin N, Hadjiliadis D, Kawut SM. Hong G, et al. Pediatr Pulmonol. 2019 Feb;54(2):133-140. doi: 10.1002/ppul.24210. Epub 2018 Dec 14. Pediatr Pulmonol. 2019. PMID: 30549449 Free PMC article.

10

The presence of Aspergillus fumigatus is associated with worse respiratory quality of life in cystic fibrosis.

Hong G, Alby K, Ng SCW, Fleck V, Kubrak C, Rubenstein RC, Dorgan DJ, Kawut SM, Hadjiliadis D. Hong G, et al. J Cyst Fibros. 2020 Jan;19(1):125-130. doi: 10.1016/j.jcf.2019.08.008. Epub 2019 Aug 21. J Cyst Fibros. 2020. PMID: 31446018 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,238 results

Search Page

Filters